Skip to content

Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis

Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02616705
Enrollment
511
Registered
2015-11-30
Start date
2015-11-30
Completion date
2019-09-30
Last updated
2022-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4-related Disease, IgG4-related Sclerosing Cholangitis

Brief summary

Immunoglobulin G4-related disease (IgG4-RD) is an uncommon inflammatory disorder that may affect multiple organ systems, including the biliary tree. IgG4-sclerosing cholangitis (IgG4-SC) can be difficult to distinguish from primary sclerosing cholangitis (PSC) or cholangiocarcinoma (CCA). The investigators aim to evaluate the sensitivity and specificity of bile for the diagnosis of IgG4-SC. Bile samples of patients with biliary strictures of various causes, including IgG4-SC, PSC, and CCA, will be collected during clinical cholangiography procedures. IgG4 will be measured in bile specimens and bile IgG4 concentrations compared between IgG4-SC, PSC, CCA, and other types of biliary strictures.

Detailed description

This study will recruit cases from Mayo Clinic Rochester and Japanese institutions such as Nagoya City University Hospital, Nagoya Daini Red Cross Hospital, and Kurashiki Central hospital. Participants will be individuals who will receive endoscopic retrograde cholangiography (ERC), endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) or percutaneous transhepatic cholangiography (PTC). Bile samples collected from the target cases will be assayed for IgG4 concentration.

Interventions

None listed

Sponsors

Nagoya University
CollaboratorOTHER
Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The presence of a biliary stricture * 18 years and older * Consented to IRB 707-03

Exclusion criteria

* Younger than 18 years of age * Unable to collect a bile sample * Abnormal postsurgical anatomy preventing collection of a bile sample

Design outcomes

Primary

MeasureTime frameDescription
Ability of bile IgG4 concentration to distinguish between IgG4-SC, PSC, and CCA.2 yearBile concentration of IgG4 will be measured in cases and controls, and the groups will be compared using appropriate statistical methods

Secondary

MeasureTime frameDescription
Correlation between bile and serum IgG4 concentrations.2 yearsThe relationship between Bile and serum IgG4 concentrations will be assessed for case and controls, using appropriate statistical methods

Countries

Japan, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026